Acid ceramidase (AC) overexpression has been observed in prostate cancer cell lines and primary tumors, and contributes to resistance to chemotherapy and radiation. The consequence of AC overexpression is the ability to convert ceramide, which is often produced as a proapoptotic response to stress, to sphingosine, which can then be converted to the prosurvival molecule sphingosine-1-phosphate. In addition to their ability to metabolize ceramide produced in response to stress, we show here that prostate cancer cell lines overexpressing AC also have increased lysosomal density and increased levels of autophagy. Furthermore, pretreatment with 3-methyladenine restores sensitivity of these cells to treatment with C 6 ceramide. We also observed increased expression of the lysosomal stabilizing protein KIF5B and increased sensitivity to the lysosomotropic agent LCL385. Thus, we conclude that AC overexpression increases autophagy in prostate cancer cells, and that increased autophagy enhances resistance to ceramide.
Introduction
Prostate cancer is the second leading cause of cancerrelated death in men in the United States. Statistical estimations for 2010 project 217 730 new cases and 32 050 deaths. 1 Nearly 1 in 6 men in the United States will be diagnosed with prostate cancer in their lifetime. 2 Although localized prostate cancer is often treated effectively, advanced disease, whether local or metastatic, is resistant to treatment and often fatal. These statistics highlight the need for elucidation of the mechanisms of resistance of prostate cancer to current treatment protocols and development of new treatment modalities.
Acid ceramidase (AC) is a ceramide-metabolizing enzyme, primarily localized to lysosomes. Ceramide is the basic building block of the complex sphingolipids, which are major structural and signaling components of cells. Ceramide is produced in response to many cellular stresses and functions as a bioactive signaling lipid in processes including apoptosis, inflammation and cell cycle arrest. Alterations in ceramide metabolism have been shown to contribute to apoptosis resistance in many types of cancer (reviewed in Ogretmen and Hannun 3 and Norris et al. 4 ). Increased transcription of AC has been observed in multiple prostate cancer cell lines compared with a benign prostatic hyperplasia cell line and in over 60% of primary tumors analyzed compared with matched normal tissue controls. 5 In addition, our group has shown that AC overexpression contributes to resistance of prostate cancer cells to both chemotherapy 6 and radiation. 7 These results suggest that the increased clearance of ceramide by overexpression of AC allows cancer cells to escape ceramide-induced apoptosis, and highlight a novel target for cancer treatment. This hypothesis is supported by a study from Morales et al., 8 who showed that daunorubicin treatment increased AC activity in hepatoma cell lines, protecting them from daunorubicin-induced cell death.
Autophagy is a mechanism of recycling cellular proteins and organelles as a function of cellular homeostasis, development or in response to stress. 9 The process involves the formation of an autophagosome to sequester cytoplasmic material, fusion with a lysosome to form an autolysosome and subsequent degradation of sequestered components by lysosomal hydrolases (reviewed in Levine and Kroemer 10 ). Evidence that many types of cancer utilize autophagy as a survival mechanism has greatly increased research interest in this field in the last decade (reviewed in Kondo et al. 11 and Klionsky 12 ). Autophagy has been shown to be critical in survival of colorectal cancer cells under low-nutrient conditions, 13 and increased autophagy in pancreatic cancer cells promotes tumor cell survival and is correlated to poor outcome. 14, 15 Recently, autophagy has been implicated in the development of resistance of breast cancer cells to the growth inhibitory effects of the anti-HER2 monoclonal antibody Trastuzumab. 16 Our group has shown previously that AC overexpression contributes to resistance of prostate cancer cells to chemotherapy and radiation, and that inhibition of AC increases susceptibility to treatment; 6, 7, [17] [18] [19] however, the role of autophagy in prostate cancer cells overexpressing AC has not been elucidated. In this study, we investigated the effects of AC overexpression on autophagy in prostate cancer cells. We show that AC overexpression results in increased autophagy and lysosomal density, which confers a survival advantage in these cells. We also observed increased expression of the lysosomal stabilizing protein KIF5B in prostate cancer cells overexpressing AC, which consequently increased their susceptibility to a lysosomal destabilizing agent. Our results suggest that prostate cancer cells overexpressing AC maintain a higher level of autophagy than parental cell lines, possibly creating an 'insult-ready' phenotype, whereby cells have a higher resistance to initial insult and can rapidly metabolize any ceramide produced.
Materials and methods
Cell lines, culture and reagents DU145 prostate cancer cell line (ATCC; Manassas, VA, USA) and PPC1 prostate cancer cell line 20 (a kind gift by Dr Yi Lu at the University of Tennessee) were cultured at 37 1C in 5% CO 2 in RPMI 1640 (Thermo Scientific HyClone; Logan, UT, USA) containing 10% bovine growth serum (Thermo Scientific HyClone) and antibiotic-antimycotic solution (Mediatech; Manassas, VA, USA). Generation of the DU145-AC-EGFP and DU145-EGFP cell lines has been described previously. 6 PPC1 cells were transfected with a pEF6/V5-His-TOPO plasmid (Invitrogen; Carlsbad, CA, USA) containing either lacZ-V5 or AC-V5 (kindly provided by Youssef Zaidan, Medical University of South Carolina; MUSC) and stable clones were obtained by long-term culture in media containing blasticidin (Invivogen; San Diego, CA, USA). LC3 cDNA was obtained from Dr Noboru Mizushima (Tokyo Medical and Dental University, Tokyo, Japan) and inserted into pEGFP-C1 (Clontech; Mountain View, CA, USA). Cell lines expressing EGFP-LC3 were obtained by transfection with the resulting plasmid, and stable clones were obtained by long-term culture in media containing G418 (Mediatech). Cell transfection was performed using TransIT-Prostate Transfection kit (Mirus Bio; Madison, WI, USA). 3-methyladenine was obtained from Sigma (St Louis, MO, USA). C 6 ceramide and LCL385 were synthesized by the MUSC Lipidomics Core Facility Synthetic Subcore (Charleston, SC, USA).
Cytotoxicity assays
Cell viability was assessed using the CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega; Madison, WI, USA). Cells were plated at approximately 5 Â 10 3 cells per well in 96-well plates and incubated overnight. The following day, media was replaced with desired treatment and after incubation, the assay was carried out according to the manufacturer's instructions.
Confocal and fluorescent microscopy and flow cytometry
Confocal microscopy was performed using a Leica laser scanning confocal microscope (Leica Microsystems, Bannockburn, IL, USA) maintained by the MUSC Hollings Cancer Center Cell and Molecular Imaging Core (1P30 CA138313-01). Enhanced green fluorescent protein was detected using 488-l excitation laser. For Lysotracker red and Acridine orange staining, cells were plated at 5 Â 10 5 cells per 60 mm culture plate and incubated overnight. The following day, media was replaced containing Lysotracker red (Invitrogen) diluted 1:2000, or Acridine orange (Sigma) at a final concentration of 0.1 mg ml À1 . Cells were incubated for 15 or 30 min (Acridine orange and Lysotracker red, respectively) at 37 1C, then trypsinized and washed twice with phosphate-buffered saline. Staining was visualized using an Olympus inverted fluorescent microscope (Olympus America, Center Valley, PA, USA) with exposure times of 200 ms (bright field) and 800 ms (red fluorescence). Lysotracker and Acridine orange staining were quantified using a Becton Dickinson FACScalibur analytical flow cytometer (BD Biosciences, San Jose, CA, USA) by the MUSC Hollings Cancer Center Flow Cytometry & Cell Sorting Core Facility.
siRNA transfection
Cells were seeded at 2 Â 10 5 cells per well in a six-well plate and incubated overnight. The following day, the cells were transfected with siRNA using Oligofectamine (Invitrogen) according to manufacturer's protocol. The scramble siRNA sequence has been described previously. 6 The AC siRNA sequences (designed by Donald Rao, Gradalis; Dallas, TX, USA) were designed based on the published sequence of AC mRNA (NM_004315). AC siRNA sequence #1 corresponds to bases from 2052 to 2076 in the 3 0 UTR (5 0 -AAGAAG TAATCAGTATGCAAAGCAA-3 0 ) and sequence #2 corresponds to bases from 800 to 824 in the coding region (5 0 -AACAGTGAATTTGGATTTCCAAAGA-3 0 ). Both siRNA sequences were purchased from Qiagen (Valencia, CA, USA).
Protein preparation and western blot
Cells were seeded in 60 mm plates as described above and treated accordingly. Cells were lifted by gently scraping the plates, washed once with ice-cold phosphate-buffered saline and then lysed by incubation on ice for 30 minutes in phosphate-buffered saline containing 1% Triton X-100, 10% glycerol and Complete Mini Protease Inhibitor Cocktail Tablet (Roche; Indianapolis, IN, USA). Insoluble material was removed by centrifugation at 14 000 r.p.m. for 15 min at 4 1C. The supernatants were supplemented with sodium dodecyl sulfate at a final concentration of 2% and stored at À80 1C. Protein concentration was determined using the BCA Protein Assay kit (Pierce; Rockford, IL, USA) according to the manufacturer's instructions. Protein (50 mg) per sample (unless otherwise indicated) were separated on NuPAGE 4-12% Bis-Tris gels (Invitrogen) and transferred to nitrocellulose membranes (Bio-Rad; Hercules, CA, USA). Membranes were blocked with 5% milk in Tris-buffered saline containing 0.1% Tween-20 and incubated overnight at 4 1C with primary antibodies: actin (Sigma); AC (BD Biosciences); LC3 (Abcam; Cambridge, MA, USA); KIF5B (Abcam). Following primary antibody incubation, membranes were washed Autophagy enhances survival of prostate cancer LS Turner et al and incubated for 1 h at room temperature with secondary antibodies: goat anti-rabbit-HRP and goat anti-mouse-HRP (Santa Cruz Biotechnology; Santa Cruz, CA, USA). Proteins were visualized using Immobilon Western HRP Substrate (Millipore; Billerica, MA, USA).
Results
Prostate cancer cells overexpressing AC are resistant to C 6 ceramide treatment and nutrient depletion
We have shown previously that prostate cancer cell lines that overexpress AC are resistant to chemotherapy and radiation, both treatments that can induce ceramide. 6, 7 To confirm these observations, DU145 prostate cancer cells overexpressing AC (DU145-AC-EGFP) and control cells (DU145-EGFP), and PPC1 prostate cancer cells overexpressing AC (PPC1-AC-V5) and control cells (PPC1-lacZ-V5) were cultured in 96-well plates and treated with C 6 ceramide. Cell viability was measured by MTS assay at 72 h after treatment. Consistent with our previous observations, overexpression of AC conferred resistance to C 6 ceramide treatment compared with control cells in both cell types (Figures 1a and b ). DU145 prostate cancer cells overexpressing AC also exhibited improved survival following 72 h in serum-free media, a condition known to induce autophagy (Figure 1c ).
Autophagy is increased in PPC1 cells overexpressing AC
As autophagy has been shown to be involved in the progression of many types of cancer, we wanted to determine whether autophagy was involved in the increased resistance to stress observed in AC overexpressing cells. We observed that PPC1-AC-V5 cells had increased expression of the autophagy protein LC3 by western blot (Figure 2a ). Following transfection with a construct coding for an EGFP-LC3 fusion protein, we observed that in cells overexpressing AC, there was an increase in the number of cells with punctate distribution of EGFP-LC3, an indicator of autophagy, versus diffuse cytoplasmic staining in control cells (Figure 2b ). To confirm that increased LC3 expression in the AC cells was due to AC overexpression, we knocked down AC expression using siRNA. Reduction in AC expression (Figure 2c) , confirming a link between AC expression and autophagy in these cells.
AC overexpression results in increased lysosomal density
As AC is primarily expressed in lysosomes, and autophagy involves fusion of autophagosomes with lysosomes, we wanted to determine whether AC overexpression altered lysosomal density in prostate cancer cells. DU145 and PPC1 prostate cancer cells overexpressing AC were stained with Lysotracker red and analyzed by flow cytometry and fluorescent microscopy. In both cell types, AC overexpression resulted in a significant increase in lysosomal staining compared with control cells when analyzed by flow cytometry (Figure 3a ). This increase was also visualized using fluorescent microscopy ( Figure 3b ). Next, we stained PPC1-AC-V5 and PPC1-lacZ-V5 cells with Acridine orange and analyzed fluorescent intensity by flow cytometry. Acridine orange stains nucleic acids and acidic organelles, resulting in green and red emission spectra, respectively, when analyzed using fluorescence. Thus, an increase in the ratio of red staining to green staining indicates an increase in acidic vesicles in the cells. PPC1-AC-V5 cells showed an increase in the red/green staining ratio compared with PPC1-lacZ-V5 cells (Figure 3c ), indicating an increase in acidic vesicular organelles in these cells.
Inhibition of autophagy improves treatment response
We next wanted to analyze whether increased autophagy in AC overexpressing cells contributes to resistance to ceramide treatment. DU145 and PPC1 cell lines were treated with 25 mM C 6 ceramide for 72 h, with or without 3-methyladenine, an inhibitor of autophagy. As observed previously, DU145-AC-EGFP and PPC1-AC-V5 cells had reduced sensitivity to C 6 ceramide treatment compared with DU145-EGFP and PPC1-lacZ-V5 cells. However, pretreatment with 3-MA increased sensitivity of both AC overexpressing cell lines to ceramide to levels comparable to control cells (Figure 4 ).
AC overexpression results in the increased expression of the lysosomal stabilizing protein KIF5B
Kinesin 5B (KIF5B) is a microtubule motor protein that associates with lysosomes and has a role in autophagy. Cardoso et al. 21 showed that KIF5B has increased association with lysosomes in the highly invasive MCF-7 breast cancer cells that overexpress an active form of ErbB2, and that KIF5B depletion resulted in perinuclear accumulation of autophagosomes and increased lysosomal membrane permeabilization. The invasive MCF-7 cells also exhibited increased expression of lysosomal proteases and altered lysosomal trafficking. Therefore, we next wanted to determine whether KIF5B expression was altered in prostate cancer cells overexpressing AC. Control cells and cells overexpressing AC were analyzed by western blot for KIF5B expression. We observed an increase in KIF5B expression in cells overexpressing AC (Figure 5a ), and knockdown of AC expression with siRNA reduced KIF5B expression ( Figure 5b ).
Prostate cancer cells overexpressing AC have increased sensitivity to lysosome destabilization
It has been shown previously that alterations in lysosome density and structure in transformed cells can actually sensitize such cells to lysosomal cell death pathways. 22 As we observed significant alterations in lysosome density as well as increased expression of Autophagy enhances survival of prostate cancer LS Turner et al the lysosome-associated protein KIF5B, we wanted to determine whether our cells were more sensitive to lysosome destabilization. For this study, we used LCL385, a lysosomotropic agent designed and developed by the Lipidomics Core Facility at the MUSC and described previously. 7,23 DU145-AC-EGFP and DU145-EGFP cells or PPC1-AC-V5 and PPC1-lacZ-V5 cells were cultured in 96-well plates in media with or without LCL385 (15 mM). Cell viability was measured by MTS assay 48 h after treatment. Compared with cells cultured in media alone, DU145-AC-EGFP and PPC1-AC-V5 cells were significantly more sensitive to LCL385 than DU145-EGFP and PPC1-lacZ-V5 cells (Figure 6 ).
Discussion
The involvement of autophagy in cancer cell biology is widely recognized and extensively published. Autophagy has been shown to serve as a protective mechanism against cell death following radiation, a treatment known to increase cellular ceramide levels. Irradiated MCF-7 cells exhibited an increased number of autophagic vacuoles, and inclusion of an inhibitor of autophagy decreased the surviving fraction by 30-40%. 24 In addition, inhibition of autophagy in radiation-resistant breast, pharyngeal, cervical, lung and rectal carcinoma cells sensitizes these cells to radiation therapy. 25 Autophagy enhances survival of prostate cancer LS Turner et al Acid ceramidase overexpression has been observed in multiple cancer cell lines and primary samples. Our group has shown previously that AC contributes to resistance to chemotherapy and radiation, and that AC inhibition improves response to treatment. 6, 7, 17, 26 We have shown here that, in addition to having an altered ceramide profile, 6 prostate cancer cells that overexpress AC have enhanced stress resistance through increased autophagy and lysosomal density (Figures 2-4 ). Increased lysosomal density likely means an increase in the amount of lysosomal cathepsins present within a cell; however, the consequence of high levels of cathepsins in the cells is an increased likelihood of cell death, should the cathepsins be released. 22 Therefore, it follows that such cells would increase the stability of the lysosomes to prevent unwanted release of cathepsins into the cytosol. In addition to our unpublished observations of increased activity of lysosomal cathepsins in cells overexpressing AC, the results presented here indicate that cells overexpressing AC have increased expression of the lysosome-associated protein KIF5B ( Figure 5 ) and are more sensitive to lysosome destabilization ( Figure 6 ). Our observations are consistent with a report by Fehrenbacher et al., 22 which showed that alterations to lysosomes induced by transformation of murine embryonic fibroblasts sensitize cells to lysosomal cell death pathways induced by various chemotherapies. Based on the results presented here and on a previous report that KIF5B knockdown in MCF-7 cells limited autophagosome formation in response to rapamycin, 21 we believe that AC overexpression in prostate cancer cells increases the basal level of autophagy in these cells through a pathway that includes KIF5B, a motor protein associated with lysosome transport. 27 The increase in autophagy complements the already enhanced resistance to stress in these cells.
As ceramide has been shown to starve cells, 28 it makes sense that mechanisms to evade this fate (overexpression of a ceramide-metabolizing enzyme and an increased activity of a cellular mechanism to buffer metabolic stress) would go hand in hand. Guenther et al. 28 showed that cellular metabolic state affects the response to ceramide; forcing cells to adapt to growth in lower nutrient levels, conditions known to induce autophagy, actually increased their resistance to ceramide treatment. Therefore, increased basal autophagy may confer a cellular advantage in response to stress. Vazquez-Martin et al. 16 reported autophagy-associated development of resistance in a breast cancer cell line chronically exposed to an anti-HER2 monoclonal antibody. SKBR3 cells cultured in the antibody ultimately increased the basal level of autophagy, and continually relied on autophagy to survive in the presence of the antibody.
Our data demonstrate that AC overexpression in PPC1 and DU145 prostate cancer cells results in increased lysosomal density and autophagy. In addition, we have shown that AC overexpression increases expression of the motor protein KIF5B, which may contribute to Autophagy enhances survival of prostate cancer LS Turner et al lysosomal stability in these cells. We believe that in addition to the increased capacity to metabolize ceramide produced in response to insult, the increased basal level of autophagy results in cells that have a heightened resistance to cellular stress. Furthermore, increased stability of lysosomes due to increased expression of KIF5B may protect cells from lysosomal membrane permeabilization and release of lysosomal contents into the cytoplasm, which would result in apoptosis. However, if this is true, this increased protection creates a therapeutic target: we have shown the AC overexpressing cells to be more sensitive to lysosome destabilizing agents than control cells. In summary, AC overexpression, previously shown to confer resistance to chemotherapy and radiation, also increases autophagy in prostate cancer cells, enhancing the ability of these cells to respond to stress, but possibly increasing sensitivity to therapeutic agents that specifically target lysosomes. Autophagy enhances survival of prostate cancer LS Turner et al
